Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Insight into the role of chondroitin sulfate E in angiogenesis.
Kastana P, Choleva E, Poimenidi E, Karamanos N, Sugahara K, Papadimitriou E. Kastana P, et al. Among authors: choleva e. FEBS J. 2019 Aug;286(15):2921-2936. doi: 10.1111/febs.14830. Epub 2019 Apr 10. FEBS J. 2019. PMID: 30932321 Free article. Review.
Genetic deletion or tyrosine phosphatase inhibition of PTPRZ1 activates c-Met to up-regulate angiogenesis and lung adenocarcinoma growth.
Kastana P, Ntenekou D, Mourkogianni E, Enake MK, Xanthopoulos A, Choleva E, Marazioti A, Nikou S, Akwii RG, Papadaki E, Gramage E, Herradón G, Stathopoulos GT, Mikelis CM, Papadimitriou E. Kastana P, et al. Among authors: choleva e. Int J Cancer. 2023 Sep 1;153(5):1051-1066. doi: 10.1002/ijc.34564. Epub 2023 Jun 1. Int J Cancer. 2023. PMID: 37260355
The Coadministration of Levosimendan and Exenatide Offers a Significant Cardioprotective Effect to Isolated Rat Hearts against Ischemia/Reperfusion Injury.
Leivaditis V, Koletsis E, Tsopanoglou N, Charokopos N, D'Alessandro C, Grapatsas K, Apostolakis E, Choleva E, Plota M, Emmanuil A, Dahm M, Dougenis D. Leivaditis V, et al. Among authors: choleva e. J Cardiovasc Dev Dis. 2022 Aug 12;9(8):263. doi: 10.3390/jcdd9080263. J Cardiovasc Dev Dis. 2022. PMID: 36005427 Free PMC article.
Pleiotrophin selectively binds to vascular endothelial growth factor receptor 2 and inhibits or stimulates cell migration depending on ανβ3 integrin expression.
Lamprou M, Kastana P, Kofina F, Tzoupis Η, Barmpoutsi S, Sajib MS, Koutsioumpa M, Poimenidi E, Zompra AA, Tassopoulos D, Choleva E, Tselios T, Mikelis CM, Papadimitriou E. Lamprou M, et al. Among authors: choleva e. Angiogenesis. 2020 Nov;23(4):621-636. doi: 10.1007/s10456-020-09733-x. Epub 2020 Jul 17. Angiogenesis. 2020. PMID: 32681389
Targeting the interaction of pleiotrophin and VEGFA165 with protein tyrosine phosphatase receptor zeta 1 inhibits endothelial cell activation and angiogenesis.
Choleva E, Menounou L, Ntenekou D, Kastana P, Tzoupis Η, Katraki-Pavlou S, Drakopoulou M, Spyropoulos D, Andrikopoulou A, Kanellopoulou V, Enake MK, Beis D, Papadimitriou E. Choleva E, et al. Eur J Pharmacol. 2024 May 29:176692. doi: 10.1016/j.ejphar.2024.176692. Online ahead of print. Eur J Pharmacol. 2024. PMID: 38821164